title: Global analysis of biogenesis, stability and sub-cellular localization of lncRNAs mapping to intragenic regions of the human genome.
abstract: Long noncoding RNAs (lncRNAs) that map to intragenic regions of the human genome with the same (intronic lncRNAs) or opposite orientation (antisense lncRNAs) relative to protein-coding mRNAs have been largely dismissed from biochemical and functional characterization due to the belief that they are mRNA precursors, byproducts of RNA splicing or simply transcriptional noise. In this work, we used a custom microarray to investigate aspects of the biogenesis, processing, stability, evolutionary conservation, and cellular localization of ∼ 6,000 intronic lncRNAs and ∼ 10,000 antisense lncRNAs. Most intronic (2,903 of 3,427, 85%) and antisense lncRNAs (4,945 of 5,214, 95%) expressed in HeLa cells showed evidence of 5' cap modification, compatible with their transcription by RNAP II. Antisense lncRNAs (median t1/2 = 3.9 h) were significantly (p < 0.0001) more stable than mRNAs (median t1/2 = 3.2 h), whereas intronic lncRNAs (median t1/2 = 2.1 h) comprised a more heterogeneous class that included both stable (t1/2 > 3 h) and unstable (t1/2 < 1 h) transcripts. Intragenic lncRNAs display evidence of evolutionary conservation, have little/no coding potential and were ubiquitously detected in the cytoplasm. Notably, a fraction of the intronic and antisense lncRNAs (13 and 15%, respectively) were expressed from loci at which the corresponding host mRNA was not detected. The abundances of a subset of intronic/antisense lncRNAs were correlated (r ≥ |0.8|) with those of genes encoding proteins involved in cell division and DNA replication. Taken together, the findings of this study contribute novel biochemical and genomic information regarding intronic and antisense lncRNAs, supporting the notion that these classes include independently transcribed RNAs with potentials for exerting regulatory functions in the cell.
authors.affiliation: a Departamento de Bioquímica ; Instituto de Química ; Universidade de São Paulo ; Sao Paulo , Brazil.
authors.forename: Ana C
authors.initials: AC
authors.lastname: Ayupe
authors.forename: Ana C
authors.initials: AC
authors.lastname: Tahira
authors.forename: Lauren
authors.initials: L
authors.lastname: Camargo
authors.forename: Felipe C
authors.initials: FC
authors.lastname: Beckedorff
authors.forename: Sergio
authors.initials: S
authors.lastname: Verjovski-Almeida
authors.forename: Eduardo M
authors.initials: EM
authors.lastname: Reis
mesh_terms: D053959:Alpha-Amanitin / Q000494:pharmacology; D001374:Azacitidine / Q000031:analogs & derivatives / Q000494:pharmacology; D045744:Cell Line, Tumor; D015254:DNA Modification Methylases / Q000037:antagonists & inhibitors / Q000378:metabolism; D003609:Dactinomycin / Q000494:pharmacology; D000077209:Decitabine; D020869:Gene Expression Profiling / Q000379:methods*; D015894:Genome, Human / Q000235:genetics*; D006367:HeLa Cells; D006801:Humans; D007438:Introns / Q000235:genetics*; D061986:MCF-7 Cells; D019384:Nucleic Acid Synthesis Inhibitors; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods; D012319:RNA Polymerase II / Q000037:antagonists & inhibitors / Q000378:metabolism; D020871:RNA Stability; D016372:RNA, Antisense / Q000235:genetics*; D062085:RNA, Long Noncoding / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D053959:Alpha-Amanitin; D019384:Nucleic Acid Synthesis Inhibitors; D016372:RNA, Antisense; D062085:RNA, Long Noncoding; D003609:Dactinomycin; D000077209:Decitabine; D015254:DNA Modification Methylases; D012319:RNA Polymerase II; D001374:Azacitidine
keywords: Intronic lncRNAs; RNA stability; RNA subcellular localization; antisense lncRNAs; eukaryotic transcription